Loading profile…
Pulling IRS BMF, Form 990 filings, peer benchmarks, programs, people, and grants.
Pulling IRS BMF, Form 990 filings, peer benchmarks, programs, people, and grants.
DBA: N/A
EIN 95-3468614 · Snapshot of IRS recognition, filing currency, financial health, and governance.
Research and development with goal of defining a microvascular index for non-invasive monitoring of vascular health and for early diagnosis of vascular related diseases. Stem cell differentiation study to optimize selection of scaffolds, cell types and stimulation for tissue regeneration of cartilage for the treatment of osteoarthritis.
Total Revenue
$496K
FY2024
Total Expenses
$336K
FY2024
Net Assets
$1.4M
Program Ratio
98.4%
expenses on programs
Employees
1
Volunteers
0
Board Members
3
Voting
2
Independent
8 answers compiled from IRS Form 990, BMF, Pub 78, and the Auto-Revocation List.